SL-164

From Wikipedia, the free encyclopedia
Jump to: navigation, search
SL-164
SL-164.svg
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
Formula C16H12Cl2N2O
Molar mass 319.185
3D model (JSmol)

SL-164 is an analogue of methaqualone developed in the late 1960s by a team at Sumitomo.[1] SL-164 has similar sedative, hypnotic and anticonvulsant properties to the parent compound, but was never marketed for clinical use.[2]

References[edit]

  1. ^ US Patent 3651230 COMPOSITIONS AND METHODS FOR TRANQUILIZING WITH SUBSTITUTED 3-PHENYL-4-QUINAZOLINONE DERIVATIVES
  2. ^ Saito, C.; Sakai, S.; Yukawa, Y.; Yamamoto, H.; Takagi, H. (1969). "Pharmacological studies on 2-methyl-3(2'-methyl-4'-chlorophenyl)-5-chloro-4H)-quinazolinone (SL-164)". Arzneimittel-Forschung. 19 (12): 1945–1949. PMID 4985336.